Burning Rock Biotech (BNR) Return on Assets: 2021-2024
Historic Return on Assets for Burning Rock Biotech (BNR) over the last 4 years, with Dec 2024 value amounting to 0.34%.
- Burning Rock Biotech's Return on Assets rose 8.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 8.00%. This contributed to the annual value of 0.34% for FY2024, which is 14.00% up from last year.
- Burning Rock Biotech's Return on Assets amounted to 0.34% in FY2024, which was up 29.40% from 0.49% recorded in FY2023.
- Over the past 5 years, Burning Rock Biotech's Return on Assets peaked at 0.33% during FY2021, and registered a low of 0.49% during FY2023.
- Over the past 3 years, Burning Rock Biotech's median Return on Assets value was 0.48% (recorded in 2022), while the average stood at 0.44%.
- In the last 5 years, Burning Rock Biotech's Return on Assets dropped by 15bps in 2022 and then grew by 14bps in 2024.
- Over the past 4 years, Burning Rock Biotech's Return on Assets (MRY) stood at 0.33% in 2021, then crashed by 46bps to 0.48% in 2022, then decreased by 2bps to 0.49% in 2023, then rose by 29bps to 0.34% in 2024.
- Its last three reported values are 0.34% in FY2024, 0.49% for FY2023, and 0.48% during FY2022.